A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Other news to note for Nov. 25, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Actimed, Aptose, Austrianova, Avant, Celltrion,...
Regulatory actions for Nov. 25, 2025
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Celltrion, Hen...
Data back spinal injury bid from Nervgen in phase Ib/IIa
Nervgen Pharma Corp. rolled out expanded findings from the Connect phase Ib/IIa study with NVG-291 in spinal cord injury patients showing that the 35-amino acid peptide...
Appointments and advancements for Nov. 24, 2025
BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. Appointments and advancements for Nov. 24, 2025 Nov. 24, 2025 New hires and promotion...
Financings for Nov. 24, 2025
BioWorld - Friday, December 26, 2025 To read the full story, subscribe or sign in. Financings for Nov. 24, 2025 Nov. 24, 2025 Biopharmas raising money in public or priv...
Other news to note for Nov. 24, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Actimed, Anaptysbio, GSK, Lava, Tesaro, Xoma.
Biggest gainers and losers for Nov. 17-21, 2025
BioWorld - Friday, December 26, 2025 To read the full article sign up for free or sign in. Biggest gainers and losers for Nov. 17-21, 2025 Nov. 24, 2025 The top 10 biop...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page